Kako citirati
Sažetak
Pacijenti koji boluju od Kovida-19 često imaju leukopeniju, najčešće limfopeniju, kao prateću laboratorijsku manifestaciju kliničkog sindroma, ali postoje indicije da na početku obolenja imaju i blagu neutropeniju. Klozapin može imati hematološke neželjene efekte u smislu leukopenije – najčešće neutropenije.
U radu je prikazan pacijent sa shizofrenijom koji je na dugogodišnjoj terapiji klozapinom. U trenutku kada se detektovala leukopenija u krvnoj slici, bio je psihički stabilan i telesno asimptomatski. Imao je smanjen broj leukocita kao jedini simptom infekcije novim koronavirusom SARS CoV 2, kojega smo potvrdili PCR-om. U ovom radu prikazujemo kliničku sliku Kovida-19 u vezi sa mogućom etiologijom preklapanja leukopenije koja se takođe može pojaviti i kao zaseban simptom infekcije koronavirusom SARS CoV 2 i biti hematološki neželjeni efekat lečenja klozapinom.
Ključne reči
Array
Array
Array
Array
Array
Array
Reference
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395:497–506.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395: 507–513.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054–1062.
Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708–1720.
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng, Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. International journal of infectious diseases. 2019; 96:131-135.
Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323: 1061–1069.
Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th ed. Cambridge: Cambridge University Press; 2013.
Li XH, Zhong XM, Lu L. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies. Psychol Med. 2020; 50: 583–594.
Stahl SM. Stahl's Essential Psychopharmacology: The Prescriber's Guide 6th ed. New York: Cambridge University Press; 2017.
Geldenhuys C, Zunza M, Tiffi N, Koen L, Decloedt EH. Clozapine-Associated Leukopenia and Agranulocytosis in Western Cape, South Africa: A 3-Year Retrospective Cohort Study. Journal of Clinical Psychopharmacology. 2021;41(3):250-254.
Mijovic A, MacCabe JH. Clozapine-induced agranulocytosis. Annals of hematology. 2020;99(11):2477-2482.
Myles N, Myles H, Xia S. Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand. 2018;138:101–109.
Munshi, HG, Montgomery, RB. Severe neutropenia: a diagnostic approach. West J Med. 2000; 172:248–252.
Zhang, X, Tan, Y, Ling, Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437-440.
Lowery SA, Sariol A, Perlman S. (2021). Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Cell Host Microbe. 2021;29(7):1052-1062.
Elbe D, Black TR, McGrane IR, Procyshyn RM. Clinical Handbook of Psychotropic Drugs for Children and Adolescents, 4th ed. Boston: Hogrefe Publishing Corporation; 2019. p.160.
Rajagopal S . Clozapine, agranulocytosis, and benign ethnic neutropenia. Postgrad Med J. 2005;81:545–546.
Gee S, Taylor D. The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine. Ther Adv Psychopharmacol [Internet]. 2020 Jul 16 [cited 2022 Mar 16];16:10:2045125320940935. Available from: Doi: 10.1177/2045125320940935
Rajić Z, Dunjić B, Milivojević G, Cvetić T, Simončević M, Mirosavljević S, et al. Uspešan oporavak pacijentkinje sa razvojem granulocitopenije tokom terapije klozapinom. Engrami. 2008;30(1):67-72.
De Leon J, Ruan CJ, Schoretsanitis G, De las Cuevas C. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89(4):200-214.